Overview

Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections

Status:
Recruiting
Trial end date:
2021-12-20
Target enrollment:
Participant gender:
Summary
This study will assess the safety and efficacy of cefepime/VNRX-5133 compared with meropenem in both eradication of bacteria and in symptomatic response in patients with cUTIs.
Phase:
Phase 3
Details
Lead Sponsor:
Venatorx Pharmaceuticals, Inc.
Treatments:
Cefepime
Cephalosporins
Meropenem
Thienamycins